Eicosanoids: Atherosclerosis and cardiometabolic health
Authors:
Open Access
- 1 March 2020
- journal article
- review article
- Published by Elsevier in Journal of Clinical & Translational Endocrinology
- Vol. 19, 100216
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- High-dose non-steroidal anti-inflammatories: painful choicesThe Lancet, 2013
- PGD Synthase and PGD2in Immune ResposneMediators of Inflammation, 2012
- Leukotrienes as Modifiers of Preclinical Atherosclerosis?The Scientific World Journal, 2012
- Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling PathwayJournal of Biological Chemistry, 2011
- Functional and pathological roles of the 12- and 15-lipoxygenasesProgress in Lipid Research, 2011
- Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in miceThe FASEB Journal, 2010
- Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in miceCardiovascular Research, 2008
- Lipid peroxidation and decomposition — Conflicting roles in plaque vulnerability and stabilityBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- A Leukocyte Type of 12-Lipoxygenase Is Expressed in Human Vascular and Mononuclear CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Prostaglandins, other eicosanoids and endothelial cellsBasic Research in Cardiology, 1985